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STAG3 truncating variant as the cause of primary
ovarian insufﬁciency
Polona Le Quesne Stabej1,5, Hywel J Williams1,5, Chela James1, Mehmet Tekman2, Horia C Stanescu2,
Robert Kleta1,2, Louise Ocaka1, Francesco Lescai1, Helen L Storr3, Maria Bitner-Glindzicz1, Chiara Bacchelli1,
Gerard S Conway*,4 and GOSgene1
Primary ovarian insufﬁciency (POI) is a distressing cause of infertility in young women. POI is heterogeneous with only a few
causative genes having been discovered so far. Our objective was to determine the genetic cause of POI in a consanguineous
Lebanese family with two affected sisters presenting with primary amenorrhoea and an absence of any pubertal development.
Multipoint parametric linkage analysis was performed. Whole-exome sequencing was done on the proband. Linkage analysis
identiﬁed a locus on chromosome 7 where exome sequencing successfully identiﬁed a homozygous two base pair duplication
(c.1947_48dupCT), leading to a truncated protein p.(Y650Sfs*22) in the STAG3 gene, conﬁrming it as the cause of POI in this
family. Exome sequencing combined with linkage analyses offers a powerful tool to efﬁciently ﬁnd novel genetic causes of rare,
heterogeneous disorders, even in small single families. This is only the second report of a STAG3 variant; the ﬁrst STAG3 variant
was recently described in a phenotypically similar family with extreme POI. Identiﬁcation of an additional family highlights the
importance of STAG3 in POI pathogenesis and suggests it should be evaluated in families affected with POI.
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INTRODUCTION
Primary ovarian insufﬁciency (POI) is deﬁned as a post pubertal
hypergonadotropic hypogonadism in women under the age of 40
years. POI presenting with secondary amenorrhoea affects an esti-
mated 1:100 women.1 However, early onset forms of POI, presenting
as primary amenorrhoea with lack of any pubertal development, affect
an estimated 1:100 000 females. Women with POI report high levels of
depression and low levels of self-esteem with negative effects on
sexuality.2 The cause of POI is not known in the majority of cases.
A growing number of genes have been identiﬁed, which harbour
variants that affect function associated with POI. The strength of
evidence linking each anomaly with POI is variable. For example, the
association of the fragile site mental retardation 1 gene (FMR1) with
POI is widely reported, whereas in others only a single case represents
the link (STAG3, NOGGIN).3–5 In some cases, the genetic link may be
indirect, such as galactose-1-phosphate uridyltransferase (GALT)
variants causing biochemical damage of the ovary and autoimmune
regulator (AIRE) variants, which trigger autoimmune damage.6 Other
possible genetic causes of POI are variants in FMR2, NR5A1, FOXL2,
INHAGDF9, NOBOX and PGRMC1, BMP15 genes on the X
chromosome (for recent review see Fortuño and Labarta7). Taken
altogether, known genes causing ovarian insufﬁciency are known to
account for less than 5% of cases; however, family studies suggest that
20–30% of women with POI have an affected relative.8 As mentioned
above, it has recently been reported that POI can result from
truncating variant in stromal antigene 3 gene (STAG3), which encodes
a subunit of cohesin; a large ring-shaped protein complex essential for
proper pairing and segregation of chromosomes during meiosis, which
is required for gametogenesis and fertility.5 In mammals, there are
four known meiosis-speciﬁc cohesin core subunits: SMC1β, RAD21L,
REC8 and STAG3. Stag3-deﬁcient female mice showed a lack of
oocytes and ovarian follicles indicating a severe ovarian dysgenesis.9
Similarly, Rec8 null mice of both sexes have germ cell failure and
are sterile and Rad21l‐deﬁcient females are fertile but develop an
age‐dependent sterility.10,11
In this report, applying a combined linkage analysis and whole-
exome sequencing approach, we replicate the role of STAG3 as




Two sisters with POI presented with primary amenorrhoea and complete lack
of any pubertal development. The proband presented at age 11 years with the
absence of pubertal development in contrast to her unaffected sister who had
demonstrated signs of puberty from age 9 years, and who subsequently
progressed through normal puberty. The proband commenced oestrogen
treatment at 13 years, with menarche achieved at 15 years of age. Breast
development remained incomplete and she underwent breast augmentation at
age 17 years. Investigations at presentation included LH 31iu/l, FSH 136 IU/l,
oestradiol undetectable o37 pmol/l and inhibin B undetectable o15.6 pg/ml.
Ovarian autoantibodies negative, karyotype 46,XX. Trans-abdominal ultra-
sound performed at age 19 years conﬁrmed the presence of a normal uterus
with bilateral 19mm adnexal structures consistent with streak gonads.
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The proband’s younger sister, aged 16 years, also presented at 11 years of age
and was started on oestrogen with satisfactory development of secondary sex
characteristics. Investigations at presentation included LH 62iu/l, FSH 130 IU/l,
oestradiol undetectable o37 pmol/l and inhibin B undetectable o15.6 pg/ml.
Ovarian autoantibodies negative, karyotype 46,XX. Menarche occurred at age 15
years. Trans-abdominal ultrasound at the age of 16 years conﬁrmed the presence
of a small but morphologically normal uterus with adnexal structures consistent
with streak gonads. Height was within the normal range for both women.
The subjects were members of a consanguineous Lebanese family and their
parents were ﬁrst cousins (Figure 1). No other females in the family were
affected. No other clinical features of note were reported. Informed consent to
the study was obtained from all participants and genetic studies were approved
by the joint UCL/UCLH ethics committee. Genomic DNA of the proband and
family members was extracted from peripheral blood by standard methods.
Linkage analysis
Multipoint parametric linkage studies of ﬁve members of the family, including
the two affected individuals and an unaffected sister, was performed using the
HumanCytoSNP-12v2-1_H Beadarray (Illumina, Inc, San Diego, CA, USA) as
per the manufacturer’s instructions as published previously.12 A recessive
transmission model with complete penetrance and a disease allele frequency of
0.0001 was used for linkage analysis.
Whole-exome sequencing
Whole-exome capture was performed with Agilent SureSelect version 3
(Agilent, Santa Clara, CA, USA), according to the manufacturer’s protocol
on the proband (II-1 in Figure 1). Enriched libraries were sequenced on the
Illumina HiSeq2000. Sequencing reads passing quality ﬁlters were aligned to the
reference genome build GRGh37/hg19 using Burrows-Wheeler Aligner (BWA)
algorithm and for variant calling we applied GATK base quality score
recalibration, indel realignment, duplicate removal and performed SNP and
INDEL discovery and genotyping using standard hard ﬁltering parameters or
variant quality score.13,14
The variant annotation and interpretation analyses were generated
through the use of Ingenuity Variant Analysis software version 3.0.20140422
(http://www.ingenuity.com/variants) from Ingenuity Systems. Exonic and
cryptic splice site variants, which were homozygous in proband, resided
in the linkage region, had a call quality ≥ 20, read depth ≥ 10 and were not
present in the internal database of 358 exomes or observed with allele
frequency ≥ 0.5% in public exome databases (1000 genomes, NHLBI ESP
exomes) were kept.
Sanger sequencing
The STAG3 variant c.1947_48dupCT (chr7.hg19:g.99798478_79dupCT) iden-
tiﬁed by exome sequencing was validated by Sanger sequencing. Segregation
was conﬁrmed in all family members (Figure 1). The following primers were
designed using Primer3 online software and used to amplify 432 nucleotides
long fragment surrounding the site of c.1947_48dupCT in STAG3: forward:
5′-GCTTGGAGAAGGTAGGGAGA-3′ and reverse: 5′-CAGCTCTTCAAGCTC
CTGC-3′.15 The variant was submitted to Leiden Open Variation Database
(http://www.lovd.nl/STAG3; patient IDs: 0029771 and 00029822).16
RESULTS
Linkage analysis
To narrow down the region of interest, we performed multipoint
parametric linkage analysis, which showed ﬁve linked regions on
chromosomes 2, 5, 7 and 16, respectively, with a logarithm of odds
(LOD) score for this consanguineous pedigree matching the one
expected of 1.93 (Figure 2). Other regions within the genome could be
excluded being causative for POI by this analysis (LOD scoreo− 2.0).
Exome sequencing
We performed whole-exome sequencing on DNA from the proband
(individual II-1; Figure 1). 66.6 Gb of sequence was generated to
achieve a mean 48x coverage. Four variants passed upstream ﬁltering:
three missense variants were present in the Single-Nucleotide Poly-
morphism Database at frequencies below 0.1%; these were
rs148227466, rs150823294 and rs139520739. The remaining variant
Figure 1 Segregation of STAG3 c.1947_48dupCT resulting in STAG3 p.(Y650Sfs*22) in a Lebanese consanguineous family. Electropherograms generated by
Sanger sequencing. Proband (II-1) is indicated by an arrow. Unaffected sister (II-3) is homozygous for the reference sequence (Ref), affected sisters (II-1 and
II-2) are STAG3 c.1947_48dupCT homozygous (CT duplication is depicted in a box) and the parents are heterozygous.
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was a two base pair duplication in exon 19 (exons numbered
according to Ensembl transcript ENST00000426455) of the
STAG3 gene (chr7.hg19:g.99798478_79dupCT; c.1947_48dupCT in
NM_012447.3) causing a frame-shift p.(Y650Sfs*22) (NP_036579). A
one base pair homozygous deletion inducing a frame-shift variant p.
(F187fs*7) in STAG3 has recently been reported as the cause of
premature ovarian failure in a large consanguineous Palestinian
family.5 STAG3 p.(Y650Sfs*22) was therefore the best disease-
causing candidate variant. STAG3 lies in a region that was linked to
POI with an expected LOD score of 1.93 (Figure 2).
Sanger sequencing
The STAG3 variant was conﬁrmed by Sanger sequencing and
segregated with the POI phenotype (Figure 1).
DISCUSSION
Exome sequencing has transformed the identiﬁcation of rare Mende-
lian disease genes as it searches for the causative variants in an
unbiased manner.17 In our study, we identiﬁed the POI affecting
variant in STAG3 in a Lebanese consanguineous family with two
affected and one unaffected females using a combination of exome
sequencing in the proband and linkage analysis. Direct whole-exome
sequencing of proband only results in 531 rare, homozygous variants;
479 (90.2%) of these variants reside outside linkage regions and hence
do not segregate with the POI phenotype. Linkage analysis was
therefore crucial in positioning of the phenotype affecting variant.
By sifting 54 667 variants identiﬁed in proband’s exome through
a series of carefully designed ﬁlters, we were able to narrow the search
for disease-causing variants to four candidate variants. The homo-
zygous TC duplication (c.1947_48dupCT), resulting in a truncated
STAG3 protein p.(Y650Sfs*22), was the most likely function affecting
variant because of linkage to the trait, the severity of the variant and
the involvement of STAG3 in meiosis, which is vital for early fetal
ovary development.18 STAG3 has 32 exons, its transcript is 4450
nucleotides and the protein is 1225 amino acids long. The
c.1947_48dupCT results in a frame-shift at amino-acid position 650
followed by a premature stop codon with exons 19–32 being omitted.
The transcript would either result in a truncated protein or would
undergo nonsense-mediated decay resulting in a loss of function.
The conﬁrmation of STAG3 p.(Y650Sfs*22) as variant affecting POI
came when, during the preparation of this manuscript, Caburet et al.
published a different STAG3 truncating variant(p.F187fs*7) as the cause
of POI in a Palestinian family.5 Caburet et al. conﬁrmed that STAG3 loss
of function is associated with POI by generating a mouse model carrying
an insertional null variant in Stag3, resulting in sterile mice with fetal
oocytes arrested at early prophase I, leading to oocyte depletion at 1 week
of age.5 It is always difﬁcult to assign causality to a gene from the evidence
of a single family even with strong evidence from animal models and so
our replication of the ﬁndings of Caburet et al.5 elevate STAG3 from the
level of a possible POI-causative gene to a conﬁrmed risk gene that has
now been identiﬁed in two unrelated families.
An interesting observation in the study by Caburet and colleagues was
that the male Stag3− /− mice were also infertile.5 In our study, the proband
had no brothers, and so the effects, if any, in males cannot be conﬁrmed.
STAG3 is part of the cohesin complex that is conserved from yeast
to man and has the ability to hold together two DNA segments within
its ring-shaped structure. When the two segments belong to sister
chromatids, cohesin is mediating cohesion, which is essential for
chromosome segregation in mitosis and meiosis and for homologous
DNA repair. Variants in cohesin and its interacting factors have been
associated with conditions as diverse as cancer and developmental
syndromes known as ‘cohesinopathies’.19 This is particularly interest-
ing given the previous report of a gonadoblastoma on the right ovary
and a complex tumour in the left ovary at the age of 19 years,5 a
ﬁnding not shared by the affected patients in our study who were last
examined at the age of 16 and 19 years, respectively. The risk of
gonadal tumour and implications with regard to genetic counselling
therefore remains to be clariﬁed.
The clinical ﬁndings of the proband and her affected sister in our
study showed a severe phenotype with streak gonads, similar to the
phenotype of the affected sisters reported previously;5 it may therefore
be a good candidate gene for other POI cases with severe phenotypes.
However, linkage analysis and homozygosity mapping in three
additional POI-affected consanguineous families excluded STAG3 as
a possible candidate gene (unpublished data), a ﬁnding in keeping
with Caburet et al. who also ruled out STAG3 locus in four other
families with obvious recessive inheritance.
Discovery of variants causing POI is challenging due to hetero-
geneity, limitation of informative families due to infertility and the
small number of known POI-causing genes. Identiﬁcation of two
distinctive homozygous truncating variants in STAG3 in consangui-
neous families of Lebanese (our study) and Palestinian origin put
Figure 2 Linkage analysis of a Lebanese consanguineous family presenting with primary ovarian insufﬁciency. Linkage plot showing logarithm of odds (LOD)
scores across the whole genome. Arrow indicates linkage to STAG3.
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STAG3 ﬁrmly on the list of candidate genes for POI, especially in
patients presenting with primary amenorrhoea. It also implicates
potential involvement of other meiosis-speciﬁc genes of the cohesin
complex in POI pathogenesis.5
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